The Clinical Dilemma of Positive Results of High-Sensitive Troponin Assays

American Journal of Cardiology

Volumn 103, Issue 9, 2009, Pages 1332-

  Lippi, Giuseppe ^a   Montagnana, Martina ^a   Guidi, Gian Cesare ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; CARDIAC PATIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; LETTER; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TROPONIN T;

EID: 65249171567     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.037     Document Type: Letter

References (8)

1. Kavsak P.A., Macrae A.R., Yerna M.J., and Jaffe A.S. Analytic and clinical utility of a next-generation, highly sensitive cardiac troponin I assay for early detection of myocardial injury. Clin Chem 55 (2009) 573-577
2. Eggers K.M., Jaffe A.S., Lind L., Venge P., and Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decision-making. Clin Chem 55 (2009) 85-92
3. Tate J.R. Troponin revisited 2008: assay performance. Clin Chem Laboratory Med 46 (2008) 1489-1500
4. Thygesen K., Alpert J.S., White H.D., Jaffe A.S., Apple F.S., Galvani M., Katus H.A., Newby L.K., Ravkilde J., and Chaitman B. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 116 (2007) 2634-2653
5. Eggers K.M., Lind L., Venge P., and Lindahl B. Will the universal definition of myocardial infarction criteria result in an overdiagnosis of myocardial infarction?. Am J Cardiol 103 (2009) 588-591
6. Diercks D.B., Kontos M.C., Weber J.E., and Amsterdam E.A. Management of ST-segment elevation myocardial infarction in EDs. Am J Emerg Med 26 (2008) 91-100
7. Zimarino M., Sacchetta D., Renda G., De Caterina R., and Facilitated P.C.I. Rationale, current evidence, open questions, and future directions. J Cardiovasc Pharmacol 51 (2008) 3-10
8. McCann C.J., and Menown I.B. New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implications. Vasc Health Risks Manag 4 (2008) 305-313